CAGR Value :
The global cytokines market was valued at US$ 22.4 billion in 2025 and is projected to reach US$ 68.5 billion by 2032, exhibiting a CAGR of 17.8% during the forecast period.
Report Studies :
Cytokines are a large group of small signaling molecules that function extensively in cellular communication. Cytokines are most often associated with various immune modulating molecules that include interleukins, chemokines, and interferons, but can also include other molecules as well. Their use in disease diagnosis and treatment has proven very beneficial over the past number of years as their use as biomarkers has been adopted as a means to understanding disease and therapies. They have expanded into more disease relevant, specialized panels for a more accurate assessment of various diseases that include cardiovascular disease, asthma, inflammation, cancer, diabetes, and rheumatoid arthritis.
By Types :
By Applications :
Cancer and Malignancy
Asthma or Airway Inflammation
Arthritis
Others
Key Industry Players
• AbbVie Inc.
• Johnson & Johnson
• Novartis International AG
• Roche Holding AG
• Pfizer Inc.
• Sanofi S.A.
• GlaxoSmithKline plc
• Bayer HealthCare Pharmaceuticals
• Amgen Inc.
• Biocon Limited
• Thermo Fisher Scientific Inc.
• Regeneron Pharmaceuticals Inc.
• Biogen Inc.